Express News | Sarepta Therapeutics Inc : JP Morgan Cuts Target Price to $197 From $202

Breakings00:23

S&P 500 Futures Climb In Premarket Trading; Target, Fabrinet Lag

Dow JonesNov 20 20:30

Barclays Initiates Sarepta Therapeutics(SRPT.US) With Buy Rating, Announces Target Price $209

Futu NewsNov 20 19:31 · Ratings

High Alpha Stocks That Are Rated 'Overweight' – MS

Seeking AlphaNov 20 03:40

Piper Sandler Maintains Sarepta Therapeutics(SRPT.US) With Buy Rating, Maintains Target Price $200

Futu NewsNov 20 00:31 · Ratings

BofA Securities Maintains Sarepta Therapeutics(SRPT.US) With Buy Rating, Maintains Target Price $210

Futu NewsNov 19 20:31 · Ratings